Form 8-K - Current report:
SEC Accession No. 0001070081-17-000126
Filing Date
2017-11-02
Accepted
2017-11-02 16:06:28
Documents
3
Period of Report
2017-11-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a1102178-kearningsrelease.htm 8-K 25356
2 EXHIBIT 99.1 ex991ptcq3earningsrelease.htm EX-99.1 173818
3 ptclogoimagea05.jpg GRAPHIC 6428
  Complete submission text file 0001070081-17-000126.txt   209366
Mailing Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449
Business Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449 9082227000
PTC THERAPEUTICS, INC. (Filer) CIK: 0001070081 (see all company filings)

EIN.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35969 | Film No.: 171172283
SIC: 2834 Pharmaceutical Preparations